Name: POC IT Solution
Brand: Roche Diagnostics

Covid-19 Roche Diagnostics

Clinical Laboratory

SARS-CoV-2 Variant Test
cobas SARS-CoV-2 Variant Set 1

The cobas SARS-CoV-2 Variant Set 1 for use on the cobas 6800/8800 Systems is an automated, multiplex, real-time RT-PCR assay for the qualitative detection and differentiation of SARS-CoV-2 mutations N501Y, deletion HV-69/70 and E484K in e.g., nasal and nasopharyngeal swab specimens from patients with known SARS-CoV-2 infection to support the understanding of variant epidemiology for Population Health Management. The assay is intended for research use only and is not for use in diagnostic procedures.

More details

SARS-CoV-2 Rapid Antibody Test
SARS-CoV-2 Rapid Antibody Test

The SARS-CoV-2 Rapid Antibody Test is a reliable, rapid chromatographic immunoassay intended for qualitative detection of antibodies (IgM and IgG) to SARS-CoV-2 in human serum, plasma or whole blood. It is intended for the use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection. The rapid lateral flow test is intended for professional use in laboratory and near patient-testing environments and qualitatively detects IgM and IgG specific to SARS-CoV-2 in serum, plasma, and whole blood.

More details

SARS-CoV-2 Rapid Antigen Test Nasal
SARS-CoV-2 Rapid Antigen Test Nasal

The SARS-CoV-2 Rapid Antigen Test Nasal is a rapid chromatographic immunoassay for the qualitative detection of SARS‑CoV‑2 nucleocapsid antigen present in human nasal samples. The test is intended to detect antigen from SARS‑CoV‑2 in individuals suspected of COVID‑19 or with known or suspected exposure to SARS‑CoV‑2. The product is intended for professional use in laboratory and Point of Care environments, or self-collection under the supervision of a healthcare worker.

More details

SARS-CoV-2 Antigen Assay
Elecsys SARS-CoV-2 Antigen

The Elecsys SARS-CoV-2 Antigen assay uses monoclonal antibodies directed against the SARS-CoV-2 N protein in a double-antibody sandwich assay format for the qualitative detection of SARS-CoV-2 in upper respiratory tract specimens.

More details

SARS-CoV-2 & Flu A/B Nucleic Acid Test
cobas SARS-CoV-2 & Influenza A/B Assay

The cobas SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, influenza A and influenza B in 20 minutes from a single nasal sample and in just one test. It is intended for use in the detection and differentiation of SARS-CoV-2, influenza A, and influenza B in clinical specimens and is not intended to detect influenza C. SARS-CoV-2, influenza A and influenza B viral RNA is generally detectable in upper respiratory specimens during infection.

More details

SARS-CoV-2 Test
SARS-CoV-2 Rapid Antigen Test

The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx. This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19 and is strictly intended for professional use in laboratory and Point of Care environment.

More details

SARS-CoV-2 Test
Elecsys Anti-SARS-CoV-2 S

The Elecsys Anti-SARS-CoV-2 S is an immunoassay for the in vitro quantitative determination of antibodies (including IgG) to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum and plasma. The assay uses a recombinant protein representing the RBD of the S antigen in a double-antigen sandwich assay format, which favors detection of high affinity antibodies against SARS‑CoV‑2. The test is intended as an aid to assess the adaptive humoral immune response to the SARS‑CoV‑2 S protein.

More details

SARS-CoV-2 & Influenza Test
cobas SARS-CoV-2 & Influenza A/B Test

The cobas SARS-CoV-2 & Influenza A/B Test is a multiplex reverse transcription polymerase chain reaction (RT-PCR) assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus in nasal or nasopharyngeal swab samples collected from individuals suspected of a respiratory viral infection consistent with COVID-19 by their healthcare provider. The test runs on the cobas 6800/8800 Systems and has a full-process negative control, positive control and internal control. It is the first commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample.

More details

SARS-CoV-2 Test
cobas SARS-CoV-2 Test

The cobas SARS-CoV-2 Test is a qualitative assay that allows the detection of nucleic acids in samples from patients who meet COVID-19 (coronavirus) clinical and/or epidemiological criteria and is intended for use on the automated, high throughput cobas 6800/8800 Systems. The single-well dual target assay includes both specific detection of SARS-CoV-2 (COVID-19 Coronavirus) and pan-sarbecovirus detection for the sarbecovirus subgenus family that includes SARS-CoV-2.

More details

Anti-SARS-CoV-2 Test
Elecsys Anti-SARS-CoV-2

The Elecsys Anti-SARS-CoV-2 is an immunoassay intended for qualitative detection of antibodies to SARS‑CoV‑2 in human serum and plasma (K2‑EDTA, K3‑EDTA, Li‑heparin) to be used as an aid in identifying individuals with an adaptive immune response to SARS‑CoV‑2, indicating recent or prior infection. The electrochemiluminescence immunoassay (ECLIA) uses a recombinant protein representing the nucleocapsid (N) antigen for the determination of antibodies against SARS-CoV-2 and is intended for use on cobas e immunoassay analyzers.

More details

IL-6 Immunoassay
Elecsys IL-6 immunoassay

The Elecsys IL-6 immunoassay is an in vitro diagnostic test for the quantitative determination of IL 6 (interleukin 6) in human serum or plasma and is used to help clinicians quickly identify COVID-19 patients with severe inflammatory response who need mechanical ventilation. The Elecsys IL-6 immunoassay is an electrochemiluminescence immunoassay (ECLIA) and is intended for use on cobas e immunoassay analyzers.

More details

News of Roche Diagnostics

Roche Completes Acquisition of TIB Molbiol Group

02 Dec 2021

Roche (Basel, Switzerland) has completed its share purchase agreement to acquire 100% of the outstanding shares of TIB Molbiol Group (Berlin, Germany).

Roche to Acquire Genmark Diagnostics to Access Novel Technology to Test for Pathogens with One Patient Sample

16 Mar 2021

Roche (Basel, Switzerland) and GenMark Diagnostics, Inc. (Carlsbad, CA, USA) have entered into a definitive merger agreement for Roche to fully acquire GenMark which provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample.

Roche Renews Partnership with Sysmex to Deliver Hematology Testing Solutions

26 Jan 2021

Under the new framework of a Global Business Partnership Agreement (GBP) signed between Roche (Basel, Switzerland) and Sysmex Corporation (Kobe, Japan), both the companies have renewed their commitment to their long standing Distribution, Sales and Service (DSS) agreement, allowing Roche to continue to distribute Sysmex hematology products, including instruments and reagents.

Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer

13 Jan 2021

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.

Roche lanza Roche Healthcare Consulting

24 Oct 2018

Roche (Basilea, Suiza) ha lanzado Roche Healthcare Consulting, un servicio de consultoría especializado que tiene como objetivo ayudar a los líderes en los laboratorios, hospitales y otros grupos de atención médica a optimizar su desempeño operativo, clínico y financiero.

Roche Launches Roche Healthcare Consulting

18 Oct 2018

Roche (Basel, Switzerland) has launched Roche Healthcare Consulting, a specialized consulting service that aims to help leaders in laboratories, hospitals and other healthcare groups optimize their operational, clinical and financial performance.

	* Required Information
	Logged in as
* Email	Already registered
Password	Wrong Password. If you have forgot password please click here.
To	Roche Diagnostics (POC IT Solution)
* Message

Member Login

Browse Products by Category

Browse Products by Category

Roche Diagnostics

Covid-19 Roche Diagnostics

Clinical Laboratory

News of Roche Diagnostics

About Roche Diagnostics

POC IT Solution

Description:

Features

Send A Message To This Supplier

More Products From This Supplier